Lupin gains as ANSM completes inspection at its Mandideep facility

06 Aug 2019 Evaluate

Lupin is currently trading at Rs. 762.00, up by 5.50 points or 0.73% from its previous closing of Rs. 756.50 on the BSE.

The scrip opened at Rs. 751.00 and has touched a high and low of Rs. 770.95 and Rs. 751.00 respectively. So far 26204 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 986.00 on 10-Sep-2018 and a 52 week low of Rs. 697.30 on 19-Jun-2019.

Last one week high and low of the scrip stood at Rs. 775.50 and Rs. 741.35 respectively. The current market cap of the company is Rs. 34468.03 crore.

The promoters holding in the company stood at 46.96%, while Institutions and Non-Institutions held 38.66% and 14.38% respectively.

The French National Agency for Medicines and Health Products Safety (ANSM) has completed the Good Manufacturing Practices (GMP) inspection at Lupin’s finished product manufacturing facility (Unit-1) at Mandideep. The inspection was conducted between April 8, 2019 and April 12, 2019. The ANSM inspection closed with no critical or major observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

1587.90 10.25 (0.65%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.